-transparent.png){kind=logo}
Clozapine is an atypical antipsychotic drug that is approved by the US Food and Drug Administration (FDA) for the treatment of psychotic disorders. Agranulocytosis is a well-established side effect of clozapine; clozapine has also been associated with other blood dyscrasias like leukocytosis, albeit rarely. In this paper, we aim to report a case of possible clozapine-associated leukocytosis in a 41-year-old woman.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Aslıhan Polat, and
Uğur Çakir, and
Nermin Gündüz
July 2010,
Clinical schizophrenia & related psychoses,
Aslıhan Polat, and
Uğur Çakir, and
Nermin Gündüz
March 2007,
The Journal of clinical psychiatry,
Aslıhan Polat, and
Uğur Çakir, and
Nermin Gündüz
January 2011,
Psychosomatics,
Aslıhan Polat, and
Uğur Çakir, and
Nermin Gündüz
May 1993,
Pharmacopsychiatry,
Aslıhan Polat, and
Uğur Çakir, and
Nermin Gündüz
October 2003,
Journal of clinical psychopharmacology,
Aslıhan Polat, and
Uğur Çakir, and
Nermin Gündüz
October 2001,
The Australian and New Zealand journal of psychiatry,
Aslıhan Polat, and
Uğur Çakir, and
Nermin Gündüz
August 2010,
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists,
Aslıhan Polat, and
Uğur Çakir, and
Nermin Gündüz
August 1995,
Journal of clinical psychopharmacology,
Aslıhan Polat, and
Uğur Çakir, and
Nermin Gündüz
July 2024,
International clinical psychopharmacology,
Aslıhan Polat, and
Uğur Çakir, and
Nermin Gündüz
January 2022,
Journal of clinical psychopharmacology,
